REACT: Remote Programming of Cardiac Implantable Electronic Device

Sponsor
University Hospital, Bordeaux (Other)
Overall Status
Recruiting
CT.gov ID
NCT05366660
Collaborator
(none)
150
1
1
21.7
6.9

Study Details

Study Description

Brief Summary

Cardiac Implantable Electronic Devices (CIEDs) such as pacemakers and implantable cardioverter defibrillators, need to be regularly interrogated and reprogrammed to ensure proper functioning. While remote monitoring allows for partial interrogation at a remote location, full interrogation and changing the CIED parameters is only possible when the patient visits a cardiologist capable of performing device programming. This can be challenging for patients and may cause unnecessary delays, particularly in settings of limited resources, enforced physical distancing, and quarantines. We aim to investigate the efficacy and safety of remote programming.

Condition or Disease Intervention/Treatment Phase
  • Other: Interrogation/programming
N/A

Detailed Description

Cardiac Implantable Electronic Devices (CIEDs) such as pacemakers and implantable cardioverter defibrillators, need to be regularly interrogated to guarantee proper functioning. In France, the follow-up of approximately 400 000 patients implanted with a CIED is performed by cardiologists. Remote monitoring allows for interrogation of contemporary CIEDs and has revolutionized the care for implanted patients. Early detection of arrhythmias, lead issues, battery depletion and algorithm side effects decreases both morbidity and mortality of CIED patients which is why today remote monitoring enjoys a class IA recommendation. While remote interrogation is advancing steadily, remote programming is not at all possible today. CIED problems may be quickly solved by changing the parameters but this is only possible when the patient visits a cardiologist capable of performing CIED programming. This can be challenging for patients and may cause unnecessary delays, particularly in settings of limited resources, enforced physical distancing, and quarantines. Remote programming of a CIED offers multiple advantages such as shorter travel distances for the patient, reduced need for presence of specialized cardiologists (in small clinics or diagnostic centers) and the possibility to offer expert support at remote locations or developing countries. At Bordeaux University, we have developed a method which enables remote programming of a CIED. The method requires the patient to be in direct vicinity of a CIED programmer, while the cardiologist specialized in CIED programming can operate the programmer from any remote location. We aim to investigate the efficacy and safety of remote programming by applying our method to implanted patients to perform remote interrogation and programming changes.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Multicenter feasibility studyMulticenter feasibility study
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Remote Programming of Cardiac Implantable Electronic Device
Actual Study Start Date :
Jun 8, 2021
Anticipated Primary Completion Date :
Dec 29, 2022
Anticipated Study Completion Date :
Mar 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: CIED's interrogation/programming

All the patients will be included in this single arm to interrogate/programm their CIED

Other: Interrogation/programming
As the study investigates remote programming, we will describe two locations: local (patient side) and remote (expert side). Local support is defined by a physician or a technician under the direct responsibility of a nearby physician who connect the patient to the remote programming system. Similar to a conventional check-up, an external defibrillator will be located in the near vicinity of the patient. The patient will first be connected to the programmer as during a conventional follow-up. The programmer will then be connected to a local PC which captures the programmer VGA video output and controls the programmer through a mouse emulator. This local PC will be remotely controlled by the remote PC using Cisco Webex, a communication software used worldwide to support telemedicine.

Outcome Measures

Primary Outcome Measures

  1. Successful remote interrogation and programming of CIED [18 months]

    Success rate of remote interrogation and programming of CIED

Secondary Outcome Measures

  1. To assess the user-friendliness of the system (1) [18 months]

    Time of the procedure (interrogation and programming)

  2. To assess the user-friendliness of the system (2) [18 months]

    Type of programming modifications done

  3. To assess the user-friendliness of the system (3) [18 months]

    Time of intallation procedure

  4. To assess the user-friendliness of the system (4) [18 months]

    Turnaround time of the command

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient of both sexes over the age of 18

  • Patients implanted with a cardiac pacemaker or an automatic defibrillator and an indication for device check-up (interrogation ± programming) which may be periodic as part of their follow-up, postoperative, following a remote monitoring alert, pre/post MRI or following symptoms.

  • Person beneficiary of social security insurance.

  • Informed consent confirmed in writing (at the latest on the day of inclusion and before any examination required by the research).

  • Women of procreating age with effective contraception

Exclusion Criteria:
  • Patients younger than 18 years old

  • Patients who are incapable to understand the study design or to give informed consent.

  • Pregnant or breastfeeding women

  • Persons placed under judicial protection, curatorship, tutorship.

  • Subject deprived of liberty on judicial or administrative decision

  • Persons participating in another study who are still in their period of exclusion

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bordeaux University Hospital Pessac France 33604

Sponsors and Collaborators

  • University Hospital, Bordeaux

Investigators

  • Principal Investigator: Sylvain MD Ploux, University Hospital, Bordeaux

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Bordeaux
ClinicalTrials.gov Identifier:
NCT05366660
Other Study ID Numbers:
  • CHUBX 2021/07
First Posted:
May 9, 2022
Last Update Posted:
May 9, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Bordeaux

Study Results

No Results Posted as of May 9, 2022